AMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Recruiting

Phase 1

AMX0114 in Adult Participants With Amyotrophic Lateral SclerosisAMX0114 in Adult Participants With Amyotrophic Lateral Sclerosis

Sponsor:

Amylyx Pharmaceuticals Inc.

Code:

NCT06665165

Conditions

ALS

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

AMX0114

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-03-29. This information was provided to ClinicalTrials.gov by Amylyx Pharmaceuticals Inc. on 2025-03-25.